8-K filed Sep 3, 2026 at 07:17 ET
Campbell's reported Q4 FY2026 results with adjusted EPS of $0.39, in line with consensus, but GAAP EPS was a loss of $(0.23) due to $117M in impairment charges. Full-year net sales fell 5% to $9.7B, and the company guided FY2027 adjusted EPS down 17-24% to $1.65-$1.80, well below the prior year's $2.17. The board also cut the quarterly dividend by 36% to $0.25/share to accelerate debt reduction. The combination of declining sales, a massive dividend cut, and weak guidance makes this a bearish filing for CPB.